91 related articles for article (PubMed ID: 12566161)
1. Expression of mBRI2 in mice.
Pickford F; Onstead L; Camacho-Prihar C; Hardy J; McGowan E
Neurosci Lett; 2003 Feb; 338(2):95-8. PubMed ID: 12566161
[TBL] [Abstract][Full Text] [Related]
2. Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.
Lashley T; Revesz T; Plant G; Bandopadhyay R; Lees AJ; Frangione B; Wood NW; de Silva R; Ghiso J; Rostagno A; Holton JL
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):492-505. PubMed ID: 18282158
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides.
Kim SH; Creemers JW; Chu S; Thinakaran G; Sisodia SS
J Biol Chem; 2002 Jan; 277(3):1872-7. PubMed ID: 11709554
[TBL] [Abstract][Full Text] [Related]
4. Modeling familial British and Danish dementia.
Garringer HJ; Murrell J; D'Adamio L; Ghetti B; Vidal R
Brain Struct Funct; 2010 Mar; 214(2-3):235-44. PubMed ID: 19779737
[TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia.
Morelli L; Llovera RE; Alonso LG; Frangione B; de Prat-Gay G; Ghiso J; Castaño EM
Biochem Biophys Res Commun; 2005 Jul; 332(3):808-16. PubMed ID: 15913558
[TBL] [Abstract][Full Text] [Related]
6. Familial British dementia: expression and metabolism of BRI.
Kim SH; Wang R; Gordon DJ; Bass J; Steiner DF; Thinakaran G; Lynn DG; Meredith SC; Sisodia SS
Ann N Y Acad Sci; 2000; 920():93-9. PubMed ID: 11193182
[TBL] [Abstract][Full Text] [Related]
7. Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain.
Akiyama H; Kondo H; Arai T; Ikeda K; Kato M; Iseki E; Schwab C; McGeer PL
Acta Neuropathol; 2004 Jan; 107(1):53-8. PubMed ID: 14586629
[TBL] [Abstract][Full Text] [Related]
8. Generation and initial characterization of FDD knock in mice.
Giliberto L; Matsuda S; Vidal R; D'Adamio L
PLoS One; 2009 Nov; 4(11):e7900. PubMed ID: 19924302
[TBL] [Abstract][Full Text] [Related]
9. [Familial non-Alzheimer dementia].
Tabira T
Rinsho Shinkeigaku; 2003 Nov; 43(11):775-8. PubMed ID: 15152461
[TBL] [Abstract][Full Text] [Related]
10. A stop-codon mutation in the BRI gene associated with familial British dementia.
Vidal R; Frangione B; Rostagno A; Mead S; Révész T; Plant G; Ghiso J
Nature; 1999 Jun; 399(6738):776-81. PubMed ID: 10391242
[TBL] [Abstract][Full Text] [Related]
11. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia.
Kim SH; Wang R; Gordon DJ; Bass J; Steiner DF; Lynn DG; Thinakaran G; Meredith SC; Sisodia SS
Nat Neurosci; 1999 Nov; 2(11):984-8. PubMed ID: 10526337
[TBL] [Abstract][Full Text] [Related]
12. Amyloid and intracellular accumulation of BRI
Garringer HJ; Sammeta N; Oblak A; Ghetti B; Vidal R
Neurobiol Aging; 2017 Apr; 52():90-97. PubMed ID: 28131015
[TBL] [Abstract][Full Text] [Related]
13. Modeling familial British dementia in transgenic mice.
Pickford F; Coomaraswamy J; Jucker M; McGowan E
Brain Pathol; 2006 Jan; 16(1):80-5. PubMed ID: 16612985
[TBL] [Abstract][Full Text] [Related]
14. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils.
El-Agnaf OM; Nagala S; Patel BP; Austen BM
J Mol Biol; 2001 Jun; 310(1):157-68. PubMed ID: 11419943
[TBL] [Abstract][Full Text] [Related]
15. Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia.
Gibson G; Gunasekera N; Lee M; Lelyveld V; El-Agnaf OM; Wright A; Austen B
J Neurochem; 2004 Jan; 88(2):281-90. PubMed ID: 14690516
[TBL] [Abstract][Full Text] [Related]
16. Role of BRI2 in dementia.
Del Campo M; Teunissen CE
J Alzheimers Dis; 2014; 40(3):481-94. PubMed ID: 24473189
[TBL] [Abstract][Full Text] [Related]
17. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.
Vidal R; Revesz T; Rostagno A; Kim E; Holton JL; Bek T; Bojsen-Møller M; Braendgaard H; Plant G; Ghiso J; Frangione B
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4920-5. PubMed ID: 10781099
[TBL] [Abstract][Full Text] [Related]
18. The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers.
Cantlon A; Frigerio CS; Freir DB; Boland B; Jin M; Walsh DM
J Biol Chem; 2015 Jul; 290(27):16502-16. PubMed ID: 25957407
[TBL] [Abstract][Full Text] [Related]
19. Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia.
El-Agnaf OM; Sheridan JM; Sidera C; Siligardi G; Hussain R; Haris PI; Austen BM
Biochemistry; 2001 Mar; 40(12):3449-57. PubMed ID: 11297410
[TBL] [Abstract][Full Text] [Related]
20. Structure and neurotoxicity of novel amyloids derived from the BRI gene.
Gibson G; El-Agnaf OM; Anwar Z; Sidera C; Isbister A; Austen BM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1111-2. PubMed ID: 16246057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
